This Continuing Education Program focuses on a number of aspects involving Patient Safety. One of the most discussed aspect of patient safety involves the concept of the safety culture within your organization. Included in this presentation are major concepts that define culture and how key the commitment from senior leadership is to its success.
Another focus of this program is the concept of reliability. The role and responsibility of management in review of their systems and processes are vital in improvements to the hospitals reliability and patient safety. Provided are some examples of process variations and workarounds. Red Rules is a safety concept that has been used successfully in other industries, however healthcare has experienced some errors in applying these rules. This program will review some of these errors while providing strategies that you can implement to improve your medication system
At the completion of this activity, the participant will be able to:
Disclosure of Conflicts of Interest
Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by Rutgers for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. Rutgers is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Robert Fakelmann, RPh., MBA has nothing to disclose.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following Rutgers School of Pharmacy planner, Vickie Georgiana and Evelyn Hermes DeSantis, PharmD, BCPS hereby state that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Haymarket Medical Education planners and managers, hereby state the following financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months:
Lynne Callea, Director of CME & Custom Publishing, has nothing to disclose. Nick Zittell, Vice President, Editorial Director, is a Stockholder of Merck & Co and Johnson & Johnson.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy and Haymarket Medical Education, do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This program is jointly sponsored by the Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy and Haymarket Medical Education.
If you have any questions relating to the accreditation of this activity, please contact vjclay@rci.rutgers.com.
Mail:
1.50
CE for Pharmacists
Ernest Mario School of Pharmacy at Rutgers The State University of New Jersey is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Ernest Mario School of Pharmacy at Rutgers The State University of New Jersey designates this continuing education activity for 1.50 of the Accreditation Council for Pharmacy Education. Universal Activity Number (UAN) 0038-9999-10-001-H05-P
To obtain credit, a score of 70% or better is required. This course is offered at $5.00 per credit to participants. (1.5 credits = $7.50 for this course). Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time